Koers Sibling Group Holdings, Inc. Other OTC
Aandelen
SIBE
US8257841010
Biotechnologie & Medisch Onderzoek
Omzet 2014 | 0,15 0,14 | Omzet 2015 | 2,21 2,05 | Marktkapitalisatie | 12,15 mln. 11,29 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -1 mln. -929K | Nettowinst (verlies) 2015 | -7 mln. -6,51 mln. | EV/omzet 2014 | 26.727.146 x |
Nettoschuld 2014 | 110K 102K | Nettoliquiditeiten 2015 | 5,29 mln. 4,91 mln. | EV/omzet 2015 | 3.109.835 x |
K/w-verhouding 2014 |
-1,83
x | K/w-verhouding 2015 |
-0,74
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 94,26% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jihad Mohammad
CEO | Chief Executive Officer | - | 20-09-23 |
Hussein A. Anani
CEO | Chief Executive Officer | - | 01-01-21 |
Mouktar Makkouk
DFI | Director of Finance/CFO | - | 20-09-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jihad Mohammad
CEO | Chief Executive Officer | - | 20-09-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,69% | 47,9 mld. | |
+46,90% | 41,42 mld. | |
-3,46% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+9,17% | 25,55 mld. | |
-20,42% | 19,27 mld. | |
+0,17% | 12,15 mld. | |
+28,07% | 12,14 mld. | |
-1,24% | 11,99 mld. |